Metabolic Syndrome In Psoriasis Vulgaris Patient

psoriasis vulgaris metabolic syndrome holistic therapy

Authors

  • Wulan Yuwita
    wulan_yoewita@yahoo.com
    Departemen/Staf Medik Fungsional Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Padjadjaran/Rumah Sakit Umum Pemerintah Dr. Hasan Sadikin Bandung, Indonesia
  • Hendra Gunawan Departemen/Staf Medik Fungsional Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Padjadjaran/Rumah Sakit Umum Pemerintah Dr. Hasan Sadikin Bandung, Indonesia
  • Unwati Sugiri Departemen/Staf Medik Fungsional Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Padjadjaran/Rumah Sakit Umum Pemerintah Dr. Hasan Sadikin Bandung, Indonesia
  • Dendi Sandiono Departemen/Staf Medik Fungsional Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Padjadjaran/Rumah Sakit Umum Pemerintah Dr. Hasan Sadikin Bandung, Indonesia
January 27, 2017

Downloads

Background: The management of metabolic syndrome in psoriasis vulgaris is rather complicated, including lifestyle modification, diet intake intervention, increasing daily activities, and managing the comorbidity factors. Purpose: Management of metabolic syndrome in psoriasis vulgaris requires holistic approach. Case: A case of metabolic syndrome with psoriasis vulgaris in a-56-year-old woman was reported with chief complaint generalized erythematous plaques, papules, scales, and hyperpigmented macules. Blood pressure was 160/90 mmHg with central obesity and waist circumference was 98 centimeters. The patient manifested with onychodystrophy and subungual hyperkeratosis digiti I pedis bilateral. Fasting blood glucose was 119 mg/dL, and triglyceride was 185 mg/dL. Management: Patient management included methotrexate, bisoprolol, captopril, simvastatin, lifestyle modification, and diabetic diet (1300 kkal and protein 0.8 mg/kg/body weight/day). Conclusion: Holistic management revealed a good response in this case. The initial psoriasis area and severity index (PASI) score before therapy was 24.8, became 9.0 after therapy on day 155th of observation.

Most read articles by the same author(s)